Gerresheimer is a speciality glass and plastics manufacturer for applications in the pharmaceutical packaging industry.
Gerresheimer is a speciality glass and plastics manufacturer for applications in the pharmaceutical packaging industry.
With operations worldwide, the company’s comprehensive portfolio includes insulin pens, micropumps, inhalers, prefillable syringes, vials, ampoules and medical containers.
Its products can be categorised into plastic / glass primary packaging, drug delivery devices and micropumps, as well as packaging for the cosmetics, nutritional supplements, life science, food and beverage industries.
Gerresheimer produces glass packaging for solid and liquid pharmaceuticals.
The company’s portfolio comprises pharmaceutical bottles, ampoules, vials, cartridges and syringes. Available in coloured and opaque opal glass varieties, its moulded glass products feature a wide range of glass categories, including borosilicate glass (type 1) and soda-silica glass (types 2 and 3). The glass can be printed or etched on request.
The Gx RTF glass syringes meet international pharmaceutical industry regulatory requirements. They can be delivered pre-sterilised and ready-to-fill or pre-filled.
Gerresheimer’s ampoules portfolio comprises type 1 pharma glass units made using flint or amber glass. With filling capacities of up to 30ml, the ampoules include closed, funnel-type or straight-stem options with break systems such as core ring, colour break ring (CBR) and one point cut (OPC)
The company’s pen and dental cartridges have fill volumes of around 1.5ml-3.0ml, with individual options such as ammonium sulphate treatment for enhanced surface resistance.
Gerresheimer’s plastics and devices division is composed of the medical plastic systems, plastic packaging and syringe systems business units.
It manufactures high-quality, customised drug delivery systems, diagnostics and medical products, focusing on inhalers, injection pens, lancing devices, laboratory disposables and point-of-care tests.
The company provides services across the creation chain, ranging from concept development to mould making and special-purpose machinery engineering in order to move medical device concepts from initial idea to market-ready products.
The Medical Plastic Systems unit develops complex plastic systems and components for customers in the pharmaceutical, diagnostics and medical technology sectors. The unit provides an individual service across all supply chain processes.
The Plastic Packaging unit’s portfolio includes plastic packaging systems for liquid and solid pharmaceuticals. Administration and dosing systems such as eye drop or nasal spray bottles and special containers for tablets and powder are some of the products in our comprehensive range of high-quality primary pharmaceutical packaging.
Duma brand multifunctional closures with tamper-evident seals, child-resistant and senior-friendly closures and integrated moisture absorbers are key product features in the Plastic Packaging range.
Syringe Systems supplements the other two business units’ portfolios with pre-fillable plastic and glass syringe systems and the relevant accessories. Gerresheimer’s highly specialised expertise and pharmaceutical-compliant technologies enable the company to offer high-quality primary packaging products to its customers in the pharmaceutical and biotech sectors.
The firm generates most of its syringe system revenues with its leading Gx RTF® brand syringes, which are supplied in a wide range of designs, in a ready-to-fill state after washing, siliconisation, pre-assembly and sterilisation.
The Life Science Research Division produces reusable laboratory glassware for research, development and analytics, such as beakers, Erlenmeyer flasks and measuring cylinders, as well as disposable laboratory products such as culture tubes, pipettes, chromatography vials and other speciality laboratory glassware.
The Advanced Technologies Division develops and manufactures intelligent drug delivery systems. The Swiss tech company Sensile Medical forms the basis of this division, where we offer pharmaceutical and biotech companies drug delivery systems with state-of-the-art digital and electronic capabilities. Its portfolio currently comprises patented micropumps, which are used to self-administer medication for Parkinson’s or heart failure, for example. Also in development is a platform for smart inhalation measurement systems.
Gerresheimer is the global partner for pharmaceutics, biotech, healthcare, and cosmetics with a very broad product range for pharmaceutical and cosmetic packaging solutions and drug delivery systems. The company is an innovative solution provider from concept to delivery of the end product.
Gerresheimer achieves its ambitious goals through a high level of innovative strength, industrial competence and concentration on quality and customer focus. In developing innovative and sustainable solutions, Gerresheimer relies on a comprehensive international network with numerous innovation and production centers in Europe, America and Asia.
Gerresheimer produces close to its customers worldwide with around 11,000 employees and generated annual revenues in 2022 of €1.8bn. With its products and solutions, Gerresheimer plays an essential role in people’s health and well-being.
Klaus Bungert Str 4
40468 Düsseldorf
Germany
Phone: +49Â 0 211 61 81 00
Fax: +49 0 211 61 81 295
Email: info@gerresheimer.com
Website: www.gerresheimer.com